# Abingworth Clinical Co-Development Co-Investment Fund, L.P. — Form D/A

Abingworth Clinical Co-Development Co-Investment Fund, L.P. of WASHINGTON, DC, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-17. $346.4M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2023-11-17
- Form: D/A
- Accession: 0001986436-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $346.4M
- Investors: 18
- Date of first sale: 2023-08-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-490264

## Issuer

- Name: Abingworth Clinical Co-Development Co-Investment Fund, L.P.
- CIK: 0001986436
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON, DC, 20004
- Phone: 202-729-5626

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy Anderson | Executive Officer | Washington, DC |
| Christina Gibbs | Executive Officer | Washington, DC |
| Elizabeth Muscarella | Executive Officer | New York, NY |
| N/A CCD-CIF General Partner, L.P. | Promoter | Washington, DC |
| N/A CCD-CIF, L.L.C. | Promoter | Washington, DC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-08-21](https://search.stillhousedata.com/formd/0001986436-23-000001) | D | — | — |

## More

- [CIK 1986436 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1986436&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001986436-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.